用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Biopharmaceutics Applications in Drug Development; Rajesh Krishna,Lawrence Yu Book 2008 Springer-Verlag US 2008 absorption.bioequivalence.

[复制链接]
楼主: Colossal
发表于 2025-3-25 06:11:30 | 显示全部楼层
发表于 2025-3-25 10:45:55 | 显示全部楼层
978-1-4419-4434-4Springer-Verlag US 2008
发表于 2025-3-25 14:56:29 | 显示全部楼层
Rajesh Krishna,Lawrence Yudiscusses state of the art knowledge in biopharmaceutics.identifies key issues and opportunities in a distinct problem-solving approach
发表于 2025-3-25 18:40:44 | 显示全部楼层
http://image.papertrans.cn/b/image/188319.jpg
发表于 2025-3-25 22:38:29 | 显示全部楼层
Molecular and Physicochemical Properties Impacting OralAbsorptionofDrugs,ase of compliance, and cost-effectiveness. Not surprisingly, desirable oral bioavailability is one of the most important considerations for the successful development of bioactive molecules. Poor oral bioavailability affects drug performance and leads to high intra- and inter-patient variability.
发表于 2025-3-26 04:01:22 | 显示全部楼层
performance is a vital aspect of new drug development as it draws on interdisciplinary expertise from both pharmaceutics and pharmacokinetics disciplines. It is at the key interface that the discipline of biopharmaceutics has emerged. The past two decades have witnessed considerable advances in bio
发表于 2025-3-26 08:02:47 | 显示全部楼层
H. J. Kölsch,P. Rairoux,J. P. Wolf,L. Wöstefulfill the same safety profile as a drug with the exception that it should not exert a therapeutic effect. Most excipients do comply with these requirements and do have the GRAS (generally regarded as safe, a system used by the US FDA) status when used in those amounts which are normally used to fabricate a drug delivery system.
发表于 2025-3-26 10:19:27 | 显示全部楼层
发表于 2025-3-26 15:31:25 | 显示全部楼层
Excipients as Absorption Enhancers,fulfill the same safety profile as a drug with the exception that it should not exert a therapeutic effect. Most excipients do comply with these requirements and do have the GRAS (generally regarded as safe, a system used by the US FDA) status when used in those amounts which are normally used to fabricate a drug delivery system.
发表于 2025-3-26 19:17:32 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-10 15:52
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表